Owkin is working with the NHS on a plan to use its AI-based system on the health service's medical records. The Google-backed firm, which uses predictive algorithms to identify biomarkers associated with cancer, would study hospital patient data in an effort to develop more effective drugs. In addition to AI, Google has also been investing heavily into machine learning and deep learning.
Owkin is working with the NHS on a plan to use its AI-based system on the health service's medical records. The Google-backed firm, which uses predictive algorithms to identify biomarkers associated with cancer, would study hospital patient data in an effort to develop more effective drugs. Owkin, which is French-American and based in New York, is currently in negotiations with three large London academic medical centres over the scheme.